Clinical Trial Update: TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating transarterial chemoembolization (TACE) combined with Methylcantharidimide tablets for large, unresectable hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Methylcantharidimide tablets (Methylcantharidimide)
• Transarterial chemoembolization (TACE)

Snippet

Sponsor: Suzhou Municipal Hospital | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: UNKNOWN